The Company reports both basic net loss per share, which is based on the weighted-average number of common stock outstanding during the period, and diluted net loss per share, which is based on the weighted-average number of common stock outstanding and potentially dilutive shares outstanding during the period.

The computations of basic and diluted net loss per share are presented in the following table (in millions, except per share amounts):


	Three Months Ended
	May 4, 2024		April 29, 2023
Numerator:
Net loss	$	(215.6)	$	(168.9)


Denominator:
Weighted-average shares — basic	865.0		856.7
Effect of dilutive securities:
Stock-based awards	—		—

Weighted-average shares — diluted	865.0		856.7






Net loss per share:
Basic	$	(0.25)	$	(0.20)
Diluted	$	(0.25)	$	(0.20)

Potential dilutive securities include dilutive common stock from stock-based awards attributable to the assumed exercise of stock options, restricted stock units and employee stock purchase plan shares using the treasury stock method. Under the treasury stock method, potential common stock outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.

Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for all periods reported above because either their exercise price exceeded the average market price during the period or the stock-based awards were determined to be anti-dilutive based on applying the treasury stock method. Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for the three months ended May 4, 2024 and April 29, 2023 due to the net losses reported in those periods.